EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alcohol-Only and Drug/Medication-Only Product-Associated Facial Injury Encounters Across COVID-19 Periods: A Public CPSC NEISS Study, 2019–2023

David M Kachar iD, Christopher T George iD, Andrea Ziegler, Eric Thorpe

Craniomaxillofacial Trauma & Reconstruction · 14.08.2026 · 19 (3) · 35

DOI: 10.3390/cmtr19030035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Craniomaxillofacial Trauma & Reconstruction, online erschienen am 14.08.2026. Verfasst von David M Kachar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous analyses of substance-involved craniofacial trauma have often combined alcohol and drug/medication involvement. We conducted a cross-sectional analysis comparing alcohol-only and drug/medication-only facial injury encounters in the public Consumer Product Safety Commission National Electronic Injury Surveillance System (NEISS), 2019–2023. Primary facial injuries (Body_Part = 76) were classified using the released Alcohol_Involved and Drug_Involved fields. Survey-weighted estimates and Taylor-linearized 95% confidence intervals incorporated the released PSU, stratum, and weight variables; design-based logistic regression evaluated code-4 hospitalization. Among 146,857 observed facial injury encounters, 4117 were alcohol-only and 2302 were drug/medication-only. Weighted annual alcohol-only proportions were stable (trend odds ratio [OR] per year, 0.99; 95% CI, 0.96–1.03; p = 0.716), whereas drug/medication-only proportions increased (OR, 1.15; 95% CI, 1.04–1.27; p = 0.009). Compared with alcohol-only encounters, drug/medication-only encounters involved older patients (weighted mean age, 63.1 vs. 47.6 years) and a lower weighted male proportion (55.6% vs. 67.5%). Weighted code-4 hospitalization was 23.1% versus 11.8%; the adjusted OR was 1.91 (95% CI, 1.45–2.53; p < 0.001). Adult-only and alternative-period sensitivity analyses supported the main conclusions. Separate classification of alcohol and drug/medication involvement revealed distinct demographic, temporal, and disposition patterns among NEISS-captured product-associated ED encounters.

Schlagwörter

Stichwörter der Autor:innen

COVID-19NEISSalcohol involvementconsumer product-associated injurydrug/medication involvementemergency departmentfacial trauma

Autor:innen und Institutionen

  • Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
  • Department of Otolaryngology-Head & Neck Surgery, Loyola University Medical Center, Maywood, IL 60153, USA.

ORCID-Profile: David M Kachar, Christopher T George

Zitieren

APA

Kachar, D. M., George, C. T., Ziegler, A., & Thorpe, E. (2026). Alcohol-Only and Drug/Medication-Only Product-Associated Facial Injury Encounters Across COVID-19 Periods: A Public CPSC NEISS Study, 2019–2023. Craniomaxillofacial Trauma & Reconstruction, 19(3), 35. https://doi.org/10.3390/cmtr19030035

Vancouver

Kachar DM, George CT, Ziegler A, Thorpe E. Alcohol-Only and Drug/Medication-Only Product-Associated Facial Injury Encounters Across COVID-19 Periods: A Public CPSC NEISS Study, 2019–2023. Craniomaxillofacial Trauma & Reconstruction. 2026;19(3):35. doi:10.3390/cmtr19030035

BibTeX
@article{Kachar2026,
  author = {Kachar, David M and George, Christopher T and Ziegler, Andrea and Thorpe, Eric},
  title = {Alcohol-Only and Drug/Medication-Only Product-Associated Facial Injury Encounters Across COVID-19 Periods: A Public CPSC NEISS Study, 2019–2023},
  journal = {Craniomaxillofacial Trauma & Reconstruction},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {35},
  doi = {10.3390/cmtr19030035}
}
Kostenlos starten →